Fundraising Fox

Biotech Growth Investors & VC Firms

747 firms in this list, with a median first check of $1M. 169 of them lead rounds. Generated from verified public data and updated continuously.

Ahren Innovation Capital
Cambridge, CambridgeshirePre-Seed–Late Stage
30 people
Houston Angel Network
HoustonPre-Seed–Growth
16 people
EQT Life Sciences
LuxembourgSeed–Late Stage$11M – $66M
39 people
VantagePoint Capital Partners
Silicon ValleySeed–Late Stage$2M – $100M
21 people
Cross Creek Advisors
Salt Lake CitySeries B–Late Stage
19 people
Kyoto University Innovation Capital
KyotoPre-Seed–Growth
20 people
Clarendon Fund Managers Ltd.
BelfastPre-Seed–Growth$25K – $3.9M
13 people
SHS Capital
TübingenGrowth–Late Stage$10M – $50M
42 people
Valor Equity Partners
ChicagoSeed–Late Stage
20 people
Primo Ventures
MilanPre-Seed–Growth$1.1M
18 people
Montage Capital
CampbellGrowth$500K – $5M
5 people
Kreos Capital
LondonSeries A–Late Stage
43 people
Artesian
AustraliaPre-Seed–Late Stage
42 people
Decheng Capital
Menlo ParkSeed–Growth
16 people
Artis Ventures
San FranciscoSeed–Late Stage$50K – $25M
7 people
Swanlaab Venture Factory
MadridSeed–Growth$540K – $3.2M
25 people
Abingworth
LondonPre-Seed–Late Stage$15M – $30M
39 people
Fortune Venture Capital
ShenzhenSeed–Late Stage$425K – $73M
11 people
UntroD Capital
TokyoPre-Seed–Growth$772K – $241M
5 people
ARCHIMED Japan
LyonGrowth–Late Stage$10.8M – $1.1B
22 people
UTEC
TokyoPre-Seed–Growth$3.1M – $78M
1 person
S32
Palo AltoSeries A–Late Stage
25 people
Agent Capital
WalthamPre-Seed–Late Stage
22 people
Ireland Strategic Investment Fund
DublinGrowth–Late Stage
37 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.